AmerisourceBergen continues its bullish rally to test new highs.
From a fundamental viewpoint, the group is in a good financial situation.
Technically, the share has a bullish configuration on all time scales. Prices are supported by increasing moving averages as shown by the 20-period, in weekly data, and enclose the stock in a dynamic upward trend.
Exceeding the technical line at USD 40.9 would point to ambitious upward targets. In this case, market participants could buy this stock with an initial target of USD 45. If investors reduce long-side exposure for profit-taking, a bearish trend would happen below USD 39.3 and so this strategy would be invalidated.
Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).
CENCORA, INC. 
